Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04621279

Cool Prime Comparative Effectiveness Study for Mild HIE

Sponsor: University of Texas Southwestern Medical Center

View on ClinicalTrials.gov

Summary

To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.

Official title: COOLPRIME: Comparative Effectiveness for Cooling Prospectively Infants With Mild Encephalopathy

Key Details

Gender

All

Age Range

36 Weeks - Any

Study Type

OBSERVATIONAL

Enrollment

460

Start Date

2023-07-19

Completion Date

2029-01-01

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

PROCEDURE

Normothermia

Usual care for first 72 hours for neonates with mild encephalopathy maintaining core temperature (36.5°C ± 1 C).

PROCEDURE

Whole body therapeutic hypothermia

Whole-body therapeutic hypothermia (33.5°C ± 0.5°C) for 72 hours began by 6 hours of age for neonates with mild encephalopathy per site standard of care practice.

Locations (1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States